_______
Dear 119th
Congress and the Trump Administration,
We, the undersigned organizations that
represent communities of all backgrounds across the country, are committed to
improving the health and well-being of underserved populations. Despite the
widespread recognition and documentation of health disparities between population
groups, many still exist and have even widened over time.(1) These
disparities often stem from broader social and economic inequalities and are driving
a variety of adverse health outcomes in our communities including higher rates
of premature death, infant mortality, and chronic health conditions.
The U.S. healthcare system needs to be
significantly reformed to address rising costs, simplify its complex structure,
and improve access to quality care. As policymakers, your leadership is crucial
to ensuring constructive reforms are implemented and our communities are
empowered to overcome pervasive health disparities. We urge your consideration
of the following information and guidelines as you and your colleagues advance
future healthcare initiatives and policies. The priorities we outline below
enjoy broad support and are directly responsive to the issues that affect
diverse communities in America today.
Confront the Rising Cost
of Healthcare
The rising cost of healthcare in the
United States translates into higher out-of-pocket costs and a lack of quality
healthcare access for underserved populations.(2) To truly lower costs
and achieve better outcomes for every patient, all healthcare stakeholders must
be held accountable for the rising cost of care. Predatory practices such as
surprise and unfair medical bills, exploitation of federal program loopholes, lack
of competition in healthcare markets, and rampant profiteering by Pharmacy
Benefit Manager (PBM) middlemen in the drug supply chain must end. Increased
government oversight and fundamental reforms are necessary to curb existing
waste, fraud, and abuse and lower costs for every patient.
Protect Critical Federal
Healthcare Programs
Protecting federal healthcare programs
like Medicare and Medicaid is crucial for ensuring the health and well-being of
millions of Americans. These programs provide essential coverage to vulnerable
populations, including seniors, low-income individuals, and people with
disabilities. They help to reduce healthcare costs for families, improve access
to preventive care, and provide a safety net for those who might otherwise go
without necessary medical treatment. For example, while private insurance
remains the primary source of coverage across racial and ethnic groups,
programs Medicaid helps fill coverage gaps for underserved patients who are disproportionally
impacted by chronic conditions.(3) Widespread cuts to these and other
critical government health programs can result in disruptions in services our
communities rely on and make the government less efficient and effective.
Promote Patient
Empowerment Across the Healthcare Sector
Patient empowerment is a concept in
healthcare that emphasizes the active role of patients in their own care. It
involves providing patients with the necessary information, resources, and
support to make informed decisions about their health and treatment options. Promoting
patient empowerment across the healthcare sector is crucial for fostering a
more equitable and effective healthcare system. Empowered patients are more
likely to be actively engaged in their own care, leading to better health
outcomes, increased adherence to treatment plans, and greater satisfaction with
their healthcare experience. When patients have access to clear information,
understand their treatment options, and feel comfortable communicating with
their providers, they can make informed decisions that align with their values
and preferences.4 This not only improves individual health but also
contributes to a more responsive and patient-centered healthcare system
overall, ultimately leading to higher quality care and better population
health.
Support Breakthrough
Medical Technologies and Innovation
Breakthrough medical technology and
innovation are crucial for advancing healthcare and improving lives. They drive
progress in preventing, diagnosing, and treating diseases, leading to better
patient outcomes and increased life expectancy. By supporting research and
development in areas like gene editing, artificial intelligence, and
personalized medicine, we can unlock new possibilities for fighting cancer,
Alzheimer's, and other debilitating conditions. It is equally important to
improve access to innovative medicines and therapies that are already available
to patients. Treatments like GLP-1s can greatly benefit patients battling
chronic conditions such as diabetes and obesity. Investing in and improving
access to these advancements not only improves individual well-being but also
strengthens our healthcare system and fosters economic growth.(5) Both
the public and private sectors must remain committed to pursuing new treatments
as more innovation and further medical breakthroughs are needed.
Improve the Representation
of Diverse Populations in Clinical Research and Data Sets
The timely collection, analysis, and
distribution of disaggregated data by public health agencies is paramount to
addressing the unique health issues faced by underserved communities. Having
rich data on diverse communities and strong representation in medical research
and clinical trials ensures that the treatments developed meet the various
needs of patients. Yet, communities of color are traditionally
disproportionately underrepresented within medical research, and data collected
on these populations is limited.(6) Disaggregated data broken down by
race, ethnicity, primary language, sex (including sexual orientation and gender
identity), disability status, age, and other sociodemographic characteristics
is critical for understanding health challenges faced by underserved
communities. Unfortunately, such data is often incomplete with many instances
of chronic undercounting. Also in clinical trials, underrepresentation is even
true among diseases and illnesses that disproportionately impact people of
color, including diabetes, heart disease, Alzheimer’s disease, and cancer.(7) Such gaps endanger potentially significant public health advancements and
undermine the value of clinical trials. To address these issues, we must work
with trusted messengers to increase awareness and develop educational programs that help to
encourage engagement from communities of color. Physicians must also have
access to trained medical interpreters to ensure diverse populations receive
the highest quality of care in the language that is most comfortable to them.
Build a Representative Healthcare
Workforce
Creating a healthcare workforce that
looks like America is essential to gaining patient trust and ensuring all
segments of our society receive quality care. Efforts within medical education
include targeted recruitment and outreach programs aimed at attracting students
from underrepresented backgrounds, holistic admissions processes that consider
a broader range of qualifications, and the creation of more comprehensive learning
environments that support the success of all students. Many institutions are
also developing pipeline programs that partner with undergraduate institutions
and community organizations to prepare students from all backgrounds for
careers in medicine.(8) Such initiatives are essential for building a
future healthcare workforce that reflects a multi-faceted population and is
better equipped to address the complex health needs of all communities.
Modernize Value-Based
Treatment and Clinical Care
When
it comes to healthcare, one size does not fit all. Lawmakers and industry
stakeholders must provide meaningful tools and personalized services to meet
the needs of underserved populations. Putting our patients and communities
first depends on steering the healthcare industry towards consumer-focused and
consumer-driven solutions, including the utilization of value-based contracts
to improve patient access and reduce out-of-pocket costs. However,
discriminatory assessments from outside entities, or other countries, that put
arbitrary numbers on
patient lives should not be used. Our infrastructure for providing home and
community-based services (HCBS) can also be improved to better meet the needs
of disadvantaged communities. Currently, too many low-income older adults and
people with disabilities are forced into institutional settings to receive the
care they need, particularly women, communities of color, and individuals with
cognitive disorders.(9) Conventional metrics to measure value to
patients, such as the Quality-Adjusted Life Year (QALY) metric, should also be
revisited to ensure these tools are not contributing to increased health
disparities.(10)
Sincerely,
Health Equity Collaborative